Company research / LTRN

Lantern Pharma Inc. (LTRN)

Build a valuation ↗↓ Download CSV

CIK 0001763950

Key ratios (year ended 2025-12-31)

-262.0%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-08-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Operating Income	-$17.98M	-$22.22M	-$17.88M	-$14.43M	-$12.59M	—	—	—
Net Income	-$17.12M	-$20.78M	-$15.96M	-$14.26M	-$12.36M	-$5.91M	-$2.43M	—
EPS (Diluted)	$-1.57	$-1.93	$-1.47	$-1.31	—	—	—	—
Total Assets	$11.04M	$25.57M	$43.65M	$58.84M	$73.95M	$20.36M	$1.43M	—
Total Liabilities	$4.50M	$4.38M	$2.74M	$2.80M	$2.38M	$660.8K	$489.3K	—
Shareholders' Equity	$6.53M	$21.19M	$40.91M	$56.04M	$71.57M	$19.70M	$943.3K	-$201.8K
Cash & Equivalents	$4.42M	$7.51M	$21.94M	$37.20M	$51.52M	$19.23M	$1.23M	$445.2K
Operating Cash Flow	-$15.68M	-$17.81M	-$14.35M	-$12.77M	-$10.59M	-$5.65M	-$2.13M	—
Capital Expenditures	$1.7K	$12.6K	$18.7K	$27.8K	$15.5K	—	—	—
Shares Outstanding	11.25M	10.78M	10.72M	10.86M	11.09M	6.22M	1.98M	—
Weighted Average Diluted Shares	10.90M	10.76M	10.84M	10.85M	—	—	—	—
EPS (Basic)	$-1.57	$-1.93	$-1.47	$-1.31	$-1.13	—	—	—